An ABUS mammogram is an automated breast ultrasound scan used alongside a standard mammogram to find cancers that dense breast tissue can hide. Unlike a traditional mammogram, which uses X-rays, ABUS uses sound waves to create three-dimensional images of the entire breast. The FDA approved it in 2012 specifically as a supplemental screening tool for women with dense breasts.
If your doctor or imaging center recommended an ABUS exam, it’s likely because your mammogram report indicated you have dense breast tissue, which roughly half of women do. Here’s what the technology is, why it matters, and what to expect.
Why Dense Breasts Need More Than a Mammogram
Dense breast tissue and tumors both appear white on a standard mammogram. This overlap makes cancers harder to spot, like finding a snowball in a snowstorm. The numbers bear this out: mammography catches about 86 to 89% of cancers in women with mostly fatty breast tissue, but that sensitivity drops to 62 to 68% in women with extremely dense breasts. That gap means a meaningful number of cancers go undetected by mammography alone.
Adding ABUS to mammography consistently improves cancer detection. Across multiple studies, the combination increases sensitivity by 6 to 35 percentage points and catches an additional 2.4 to 4.3 cancers per 1,000 women with dense breasts. Those extra detections are the whole reason ABUS exists: it fills in the blind spots that mammography leaves behind.
How ABUS Works
ABUS uses a wide, curved transducer that is much larger than the small probe used in a traditional handheld ultrasound. This transducer is placed on the breast along with a thin disposable membrane and skin lotion to ensure smooth, even contact. Once positioned, the device automatically sweeps across the breast, capturing thousands of ultrasound images that are stitched together into a 3D volume.
The scan typically covers the breast from multiple angles. Because the transducer is curved and wide, it compresses the breast uniformly and captures a large field of view in a single pass, using broad 25-millimeter beams rather than the narrow, focused beam of a handheld probe. You lie on your back during the exam, and the technologist positions the transducer for each view. The entire process for both breasts generally takes about 15 to 20 minutes.
There’s no radiation involved. Like all ultrasound, ABUS uses sound waves, making it safe for repeated use.
ABUS vs. Handheld Ultrasound
You might wonder why a specialized automated system is needed when handheld breast ultrasound already exists. The key difference comes down to consistency. Handheld ultrasound is highly operator-dependent, meaning the quality and completeness of the exam varies based on who is performing it and how much experience they have. A less experienced operator might miss areas of the breast or produce images that are harder to interpret.
ABUS removes most of that variability. Because the machine controls the scanning motion, any trained technologist (not necessarily a physician or sonographer) can acquire the images. The radiologist then reviews the full 3D dataset at a workstation afterward, at their own pace, focused entirely on interpretation rather than image acquisition. This separation of tasks is a meaningful advantage. It also means a second radiologist can independently review the same images if there’s any doubt about a finding, something that isn’t practical with handheld ultrasound since those images exist only as the operator captured them in real time.
In terms of diagnostic accuracy, studies show ABUS and handheld ultrasound perform similarly. The practical advantages of ABUS are standardization, reproducibility, and the ability to document the entire breast volume for later review.
What ABUS Cannot Do
ABUS is a supplement to mammography, not a replacement. One important limitation is its ability to detect microcalcifications, which are tiny calcium deposits that can be an early sign of certain breast cancers. Mammography remains the gold standard for spotting these. Microcalcifications that sit outside of a mass, scattered in fatty or fibrous tissue, are particularly difficult for ultrasound to pick up because they don’t cast the acoustic shadows that make them visible on a sound-wave image.
Adding ABUS to mammography also comes with a trade-off: higher recall rates. That means more women will be called back for additional imaging or biopsies that turn out to be benign. Specificity (the ability to correctly identify someone as cancer-free) drops modestly when ABUS is added. For most women with dense breasts, the benefit of catching cancers earlier outweighs the inconvenience and anxiety of occasional false alarms, but it’s worth knowing this going in.
Insurance and Access
Coverage for ABUS varies. In March 2023, the FDA updated its regulations to require that all breast imaging centers notify patients of their breast density after every mammogram. This federal rule builds on what many states had already been doing: as of the most recent count, more than half of U.S. states require that density information be included in mammography reports.
A smaller number of states go further. Connecticut, Illinois, and New Jersey have enacted laws mandating that insurers cover supplemental screening exams for women with dense breasts. Indiana requires the same for state employee health plans. Outside of these states, coverage depends on your specific insurance plan. If you’ve been told you have dense breasts and want ABUS, it’s worth calling your insurer to confirm whether the exam is covered before scheduling.
ABUS technology is becoming more common but is still not available at every imaging center. Larger medical centers and breast imaging specialists are the most likely to offer it.
Who Should Consider ABUS
The primary candidates are women who have no breast symptoms and whose mammograms show heterogeneously dense or extremely dense breast tissue (the two densest categories on the standard four-level scale). If your mammogram report mentions dense tissue, that’s the trigger. ABUS is a screening tool, meaning it’s designed for women without lumps, pain, or other concerning signs. If you do have symptoms, your doctor will likely recommend a diagnostic handheld ultrasound or other targeted imaging instead, since those exams can be directed at a specific area of concern in real time.